Center for Integrative Neuroplasticity, Department of Bioscience, University of Oslo, Oslo, Norway.
Nat Commun. 2023 Feb 4;14(1):608. doi: 10.1038/s41467-023-36324-3.
Genetically encoded Ca indicators (GECIs) are widely used to measure neural activity. Here, we explore the use of systemically administered PHP.eB AAVs for brain-wide expression of GECIs and compare the expression properties to intracerebrally injected AAVs in male mice. We show that systemic administration is a promising strategy for imaging neural activity. Next, we establish the use of EE-RR- (soma) and RPL10a (Ribo) soma-targeting peptides with the latest jGCaMP and show that EE-RR-tagged jGCaMP8 gives rise to strong expression but limited soma-targeting. In contrast, Ribo-tagged jGCaMP8 lacks neuropil signal, but the expression rate is reduced. To combat this, we modified the linker region of the Ribo-tag (RiboL1-). RiboL1-jGCaMP8 expresses faster than Ribo-jGCaMP8 but remains too dim for reliable use with systemic virus administration. However, intracerebral injections of the RiboL1-tagged jGCaMP8 constructs provide strong Ca signals devoid of neuropil contamination, with remarkable labeling density.
基因编码钙指示剂(GECIs)被广泛用于测量神经活动。在这里,我们探索了系统给药 PHP.eB AAV 用于大脑范围的 GECIs 表达,并将其与雄性小鼠脑内注射的 AAV 进行了比较。我们表明,系统给药是一种很有前途的成像神经活动的策略。接下来,我们建立了使用最新的 jGCaMP 的 EE-RR-(体)和 RPL10a(Ribo)体靶向肽,并表明 EE-RR 标记的 jGCaMP8 产生了强烈的表达,但体靶向有限。相比之下,Ribo 标记的 jGCaMP8 缺乏神经突信号,但表达率降低。为了解决这个问题,我们修饰了 Ribo 标记的连接区(RiboL1-)。RiboL1-jGCaMP8 的表达速度快于 Ribo-jGCaMP8,但对于系统病毒给药仍太暗,无法可靠使用。然而,脑内注射 RiboL1 标记的 jGCaMP8 构建体提供了没有神经突污染的强 Ca 信号,具有显著的标记密度。